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One hundred sixteen patients were evaluated to determine the 
ability of single photon emission computed tomographic (SPECT) 
thallium-201 exercise and redistribution imaging to detect silent 
ischemia secondary to restenosis in asymptomatic patients after 
single and multiple vessel percutaneous transluminal coronary 
angioplasty and the findings were compared with SPECT imaging 
detection of restenosis in symptomatic patients. The value of 
exercise electrocardiography (ECG) and the amount of ischemic 
myocardium in symptomatic and asymptomatic patients were 
determined. Forty-one patients were asymptomatic after angio-
plasty; 77% of these had chest pain before angioplasty. Seventy-
five patients had chest pain after angioplasty; 99% of these had 
chest pain before angioplasty. 
Restenosis occurred in 61 % of asymptomatic and 59% of 
symptomatic patients and in 46 % of the vessels in both asympto-
matic and symptomatic patients. Sensitivity, specificity and accu-
racy for detection of restenosis by SPECT in individual patients 
were 96%, 75% and 88% versus 91 %, 77% and 85%, respec-
tively, in the asymptomatic versus symptomatic groups (p = NS). 
After coronary angioplasty, 19% to 33% of patients with 
restenosis are asymptomatic (1-3). These patients are at high 
risk for the consequences of silent ischemia. The purpose of 
this study was to determine the role of single photon 
emission computed tomographic (SPECT) thallium-201 ex-
ercise and redistribution imaging in the evaluation of silent 
ischemia secondary to restenosis in asymptomatic patients 
after coronary angioplasty and to compare it with the eval-
uation of symptomatic patients with respect to detection of 
restenosis and amount of ischemic myocardium and compar-
ison with exercise electrocardiography (ECG). 
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Sensitivity, specificity and accuracy for restenosis detection in 
individual vessels were 90%,89% and 89% versus 84%,77% and 
84%, respectively, in the asymptomatic and symptomatic groups 
(p = NS), with similar results for the three major arteries. 
Sensitivity and accuracy of exercise ECG were significantly less 
than those ofSPECT imaging for the patients with silent (40% and 
44%) and symptomatic (59% and 64%) ischemia (p < 0.001). 
Restenosis of vessels in the patients with silent and symptomatic 
ischemia was associated with an equal amount and degree of 
severity of ischemic myocardium in the two groups. 
It is concluded that 1) restenosis may occur without angina 
despite the presence of angina before coronary angioplasty. 
2) Exercise ECG is inaccurate in detecting silent ischemia result-
ing from restenosis. 3) SPECT accurately identifies restenosis in 
both asymptomatic and symptomatic patients. 4) The amount of 
ischemic myocardium does not differ in silent and symptomatic 
restenosis. 
(J Am Coll CardioI1991;17:670-7) 
Methods 
Study patients. The study group consisted of 116 consec-
utive patients referred for evaluation of possible restenosis 
after angioplasty. These patients underwent SPECT thallium 
imaging within 1 week before coronary angiography. The 
mean time of referral was 6 months after angioplasty. 
Forty-one patients were entirely asymptomatic after angio-
pia sty and constitute the silent ischemia study group. 
Twelve of these patients (29%), because they had no chest 
pain or anginal equivalent before angioplasty and conse-
quently could not be expected to have symptoms with 
restenosis, were scheduled for SPECT imaging and angiog-
raphy no later than 6 months after angioplasty. Twenty-nine 
patients (71%) had angina before angioplasty but were 
asymptomatic afterward. Seventeen of these patients had 
unusually complex angioplasty and were scheduled for 
angiographic and SPECT reevaluation from the time of the 
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initial intervention, irrespective of development of symp-
toms. The other 12 asymptomatic patients were referred for 
reevaluation by their primary physicians, who, as part of 
their practice pattern, had ordered an exercise test with 
(eight patients) or without (four patients) thallium-20l imag-
ing, that was abnormal. Seventy-five patients had chest pain 
after angioplasty and constitute the symptomatic ischemia 
group. All patients in this group had recurrent chest pain 
after an initial symptom-free period. All patients gave in-
formed consent before evaluation. 
Exercise protocol and thallium imaging procedure. All 
patients underwent standard Bruce protocol exercise testing 
to a symptom-limited maximum (4). The standard 12 lead 
ECG during exercise was considered positive if there was 
;::: 1 mm of horizontal or downs loping ST depression for at 
least 0.08 s after the J point compared with the tracing 
recorded at rest. Five patients, three in the symptomatic and 
two in the silent ischemia group, had baseline ST depression 
> 1 mm that precluded accurate analysis of further ST-
segment changes with exercise and were excluded from 
analysis of ECG restenosis detection. One minute before the 
termination of exercise, 3 mCi of thallium-20 1 was injected. 
SPECT images were obtained 10 min after isotope injection 
and 3 to 5 h later and, when indicated, 24 h later. A Siemens 
Orbiter large-field-of-view tomographic camera interfaced 
with a Medical Data Systems A3 computer was used. The 
camera was equipped with 75 photomultiplier tubes, a 
0.25 in. (0.64 cm) thick NaI crystal and an all-purpose, 
parallel-hole collimator. A 20% energy window was posi-
tioned on the 80 keY photopeak and a second 15% energy 
window was centered on the high energy peak of thallium-
201. Thirty-two equidistant projections were obtained for 40 
s each for the exercise and 4 h images and for I min for the 
24 h images over a 1800 rotation from the 45" right anterior 
oblique to the 450 left posterior oblique position. Data were 
stored on magnetic disc with use of a 64 x 64, 16 bit matrix. 
Each of the 32 projections was corrected for nonuniformity 
with a cobalt-57 source, collecting 30 million counts. The 
mechanical center of rotation was determined to align the 
detector data with respect to the reconstruction matrix and 
to monitor gantry stability. The raw data were smoothed 
with use of a nine-point weighted averaging system. Filtered 
back projection was performed with use of a Butterworth 
filter with a cutoff frequency of 0.2 cycles/pixel and order 5. 
Tomograms were reoriented in the short-axis, vertical 
long-axis and horizontal long-axis planes, reconstructed at 1 
pixel/slice, representing approximately 6.2 mm thickness, 
and normalized and displayed with the maximal pixel value 
set at 100%. The short-axis slices were separated into six 
equal segments (anterior, anteroseptal, inferoseptal, infe-
rior, inferolateral and anterolateral) at apical, mid and basal 
ventricular levels. The vertical long-axis slices were divided 
into anterior, apical and inferior segments from septal to 
lateral surfaces and the horizontal long-axis slices were 
divided into the superior septal, inferoseptal, apical, super-
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Figure 1. Separation of SPEer thallium myocardial images into 20 
myocardial segments. Anterior = 1,7,13; anteroseptal = 2,8,14; 
inferoseptal = 3,9,15; inferior = 4,10,16; inferolateral = 5,11,17; 
anterolateral = 6,12,18; anteroapical = 19; inferoapical = 20. 
Reprinted from Hecht et al (9). 
olateral and inferolateral segments from the superior to the 
inferior portions of the heart. 
Qualitative analysis of each segment of the exercise and 
redistribution views was performed on a 0 to 4 scale (0 = 
normal, 1 = equivocally reduced thallium uptake, 2 = mildly 
reduced uptake, 3 = moderately reduced uptake, 4 = 
severely reduced uptake) by two independent observers. 
Scores ;:::2 were considered abnormal and differences of 
opinion were resolved by consensus. Polar maps were 
generated (5) and used for confirmation of visual analysis. 
Ischemia was categorized as either total or partial nor-
malization of a segment from exercise to redistribution 
imaging with a minimal improvement of one point on the 
visual scale. 
Coronary arteriography. All patients underwent selec-
tive coronary arteriography within a week after SPECT 
exercise imaging. Selective left and right coronary arterio-
grams were obtained by either the Judkins or the Sones 
approach. Restenosis was defined as return of a previously 
dilated vessel to ;:::50% diameter reduction, determined by 
magnified electronic caliper measurements (6). 
SPECT image-vascular territory correlations. The SPECT 
image regions were assigned to the distribution of individual 
vessels guided by the coronary anatomy obtained from the 
angiogram performed before the angioplasty, as follows: 
anteroseptal, anterolateral, superolateral and anterior to the 
left anterior descending coronary artery; inferolateral to the 
left circumflex coronary artery; inferior and inferoseptal to 
the right coronary or left circumflex coronary artery, de-
pending on the right or left dominance of the circulation. The 
apex was assigned to whichever vessel supplied this area as 
determined from the pre-angioplasty angiogram. Absence or 
presence of restenosis was predicted before angiographic 
reevaluation on the basis of presence or absence of ischemic 
redistribution in the territory of the individual vessels. 
To evaluate the extent of the myocardial ischemia asso-
ciated with restenosis, only 20 segments were used (Fig. I) 
to avoid duplication of the same anatomic area on different 
projections. The number of segments, score of each segment 
and sum of the scores from each segment demonstrating 
ischemic redistribution assigned to the individual vessels 
(severity score) were determined and used as a measure of 
the geographic extent and severity of ischemia. 
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Table 1. Characteristics of 116 Patients 
Silent Symptomatic 
Ischemia Ischemia 
(n = 41) (n = 75) 
Age (yr) 62.1 ± 9.8 56.4 ± 8.1 * 
Gender (male) 90% 75%t 
Prior myocardial infarction 41% 43% 
Diabetes mellitus 15% 4%t 
Antianginal drugs 95% 89% 
Calcium channel blockers 88% 84% 
Nitrates 43% 55% 
Beta-adrenergic blockers 3% 8% 
Chest pain before 71% 99%* 
angioplasty 
Months after angioplasty 6.6 ± 3.2 6.0 ± 2.9 
(mean ± SO) 
*p < 0.01; tp < 0.05. 
Statistical analysis. Continuous variables are expressed 
as mean values ± SD. Student's t tests were performed to 
determine significant differences between mean values for 
the continuous variables. Chi-square analyses or Fisher's 
exact tests were used to compare categorical variables. In 
situations (primarily in comparing sensitivity, specificity and 
accuracy by vessel) where multiple comparisons were per-
formed, the Bonferroni method was used to adjust signifi-
cancelevel. 
Results 
Patient characteristics and exercise performance (Tables 1 
and 2). Patients with silent ischemia were significantly older 
and were more likely to be male. A significantly larger 
proportion of patients with silent ischemia had diabetes 
mellitus (15% versus 4%, p < 0.05). Similar high proportions 
of patients were taking antianginal medications. Seventy-one 
percent of the patients with silent ischemia had chest pain 
before coronary angioplasty, compared with 99% of the 
patients with symptomatic ischemia (p < 0.01). None of the 
patients with silent ischemia and 41% with symptomatic 
ischemia had chest pain during the treadmill test (p < 0.001). 
The patients in both groups were studied at similar time 
intervals after angioplasty. Exercise performance in both 
groups was virtually identical, with similar exercise dura-
Table 2. Exercise Performance in 116 Patients 
Exercise duration (min) 
Metabolic equivalents (METs) 
Maximal heart rate (beats/min) 
Maximal blood pressure (mm Hg) 
Chest pain during exercise test 
*p < 0.001. 
Silent 
Ischemia 
(n = 41) 
7.8 ± 3.1 
10.1 ± 2.9 
141 ± 13 
173 ± 21 
0% 
Symptomatic 
Ischemia 
(n = 75) 
7.4 ± 2.9 
9.7 ± 3.2 
139 ± 12 
168 ± 18 
41%* 
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Table 3. Coronary Arteriography in 116 Patients 
Silent Painful 
Ischemia Ischemia 
(n = 41) (n = 75) 
Single vessel angioplasty 54% 52% 
Multivessel angioplasty 46% 48% 
Total vessels dilated 65 120 
Left anterior descending 32 51 
Right coronary 19 43 
Left circumflex 14 26 
Patients with restenosis 61% 59% 
Vessels with restenosis 
Total vessels 46% 46% 
Left anterior descending 44% 59% 
Right coronary 53% 33% 
Left circumflex 43% 42% 
Diameter reduction 
Immediately before angioplasty 80 ± 14% 77 ± 13% 
Immediately after angioplasty 22 ± 12% 23 ± 14% 
At time of restudy 76 ± 17% 81 ± 14% 
tion, metabolic equivalents, maximal heart rate and maximal 
blood pressure. 
Coronary arteriography (Table 3). The coronary arterio-
graphic characteristics of patients with silent and sympto-
matic ischemia were remarkably similar both before and 
after angioplasty. Approximately half of the patients in both 
groups underwent single vessel and multiple vessel angio-
plasty. The left anterior descending artery, right coronary 
artery and left circumflex coronary artery were represented 
in equal proportions in both groups. Sixty-one percent of 
patients with silent ischemia and 59% with symptomatic 
ischemia had restenosis in at least one vessel. Among those 
with silent ischemia, restenosis occurred in 67% with angina 
before angioplasty and 70% of those without angina (p = 
NS). Fifteen percent of the asymptomatic patients with 
restenosis had diabetes mellitus, compared with 4% of 
symptomatic patients (p < 0.05). In both groups 46% of 
vessels had restenosis. There were no significant differences 
in the proportion of the individual vessels undergoing re-
stenosis, Similarly, percent diameter reduction immediately 
before and immediately after angioplasty and at the time of 
restudy were almost identical in both groups. 
SPECT imaging versus exercise ECG (Table 4). SPECT 
thallium imaging was significantly more sensitive in patients 
with silent ischemia (96% versus 40%, p < 0,001) and 
accurate (88% versus 44%, p < 0,001) than was exercise 
ECG in detecting ischemia with similar specificity. In pa-
tients with symptomatic ischemia, SPECT was also more 
sensitive (91% versus 59%, p < 0.001) and accurate (85% 
versus 64%, p < 0.001) than was exercise ECG, and speci-
ficity was again similar. SPECT imaging was equally sensi-
tive, specific and accurate in patients with silent or sympto-
matic ischemia. Exercise ECG was significantly more 
accurate in patients with symptomatic than with silent ische-
mia (64% versus 44%, p < 0.05). 
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Table 4. Detection of Restenosis After Angioplasty by SPECT 
Thallium Imaging and Exercise ECG: Silent Versus 
Symptomatic Ischemia 
Sensitivity Specificity Accuracy 
(%) (%) (%) 
Silent Ischemia 
SPECr 96* 75 88* 
Exercise ECG 40 50 44t 
Symptomatic Ischemia 
SPECr 91* 77 85* 
Exercise ECG 59 71 64 
*p < 0.001 vs exercise ECG; t p < 0.05 vs symptomatic ischemia. 
Detection of restenosis in individual vessels (Table 5). 
There were no differences in detection of individual vessel 
restenosis by SPECT imaging between patients with silent 
and symptomatic ischemia (sensitivity 90% and 84%. speci-
ficity 89% and 77% and accuracy 89% and 84%, respectively. 
for all vessels). Detection of restenosis in specific arteries 
was also similar. 
Severity of ischemia (Table 6). The number of ischemic 
segments and severity score of ischemia were similar in 
patients with silent and symptomatic restenosis for each of 
the coronary arteries. Examples of silent ischemia on 
SPECT imaging are shown in Figures 2 and 3. 
Discussion 
This study shows that SPECT thallium imaging is useful 
for evaluating restenosis in asymptomatic and symptomatic 
patients after angioplasty and that restenosis jeopardizes 
equivalent amounts of myocardium, irrespective of presence 
or lack of symptoms. 
Clinical and arteriographic patterns. The group of pa-
tients with silent ischemia had a larger proportion of men and 
patients with diabetes and a mean older age. The higher 
incidence of diabetes among asymptomatic patients with 
restenosis is consistent with a prior report (7) of a higher 
incidence in exercise-induced silent ischemia and is at odds 
with others (8-10). The discrepancy might be the result of 
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Table 5. Detection of Restenosis in Individual Vessels by SPECT 
Thallium Imagining: Silent Versus Symptomatic Ischemia 
Silent ischemia 
All vessels 
Left anterior descending 
Right coronary 
Left circumflex 
Symptomatic ischemia 
All vessels 
Left anterior descending 
Right coronary 
Left circumflex 
Sensitivity 
(%) 
90 
93 
90 
83 
84 
87 
86 
83 
Specificity 
(%) 
89 
89 
100 
75 
77 
100 
72 
75 
Accuracy 
(%) 
89 
91 
95 
79 
84 
92 
77 
81 
varying definitions of silent ischemia. Although the inci-
dence of chest pain before angioplasty was significantly 
lower among patients with silent ischemia, 71% did have 
angina before angioplasty. Moreover, 76% of the patients 
with asymptomatic restenosis had chest pain before angio-
plasty. Thus. the presence of angina before angioplasty does 
not mean that restenosis will be accompanied by angina. 
Coronary patency should not be assumed simply because 
symptoms are absent. 
Our study group was not a consecutive series of patients 
who had undergone angioplasty, but rather a consecutive 
series in whom SPECT imaging and arteriography were 
obtained within a I-week period. It. is therefore subject to 
numerous sources of selection bias. which are more promi-
nent in the asymptomatic group. The 60% incidence of 
restenosis in the symptomatic patients is consistent with 
prior reports of 50% to 56% in nonselected series (1,2) and is 
very likely more representative of the group of patients with 
symptoms after angioplasty who are referred because of the 
common denominator of recurrent chest pain. On the other 
hand, asymptomatic patients are not routinely evaluated and 
the 59% restenosis rate in this group cannot be construed as 
the frequency of restenosis in the general population of 
asymptomatic patients, which has been reported as 14% to 
16% (1.2.11). Selection was used in the decision to restudy 
Table 6. Severity of Ischemia by SPECT Thallium Imaging: Silent Versus Symptomatic Restenosis 
LAD RCA LCx 
Silent restenosis 
No. of vessels 14 10 6 
Ischemic segments/vessel 7.8 ± 4.3 4.3 ± 1.4 3.5 ± 1.7 
Score/segment 2.4 ± 0.7 2.7 ± 0.7 2.3 ± 0.4 
Severity score/vessel 19.8 ± 15.4 12.0 ± 7.1 8.3 ± 4.8 
Symptomatic restenosis 
No. of vessels 30 14 II 
Ischemic segments/vessel 7.6 ± 3.9 3.7 ± 1.2 2.3 ± 0.9 
Score/segment 2.6 ± 0.6 2.4 ± 0.5 2.6 ± 0.7 
Severity score/vessel 21.1 ± 14.0 9.1 ± 4.0 5.9 ± 3.3 
LAD = left anterior descending coronary artery; RCA = right coronary artery; LCx = left circumflex coronary 
artery. 
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Figure 2. SPECr thallium images in a 55 year old asymptomatic 
man with prior inferior myocardial infarction and total right coro-
nary artery obstruction, 4 months after left anterior descending and 
obtuse marginal angioplasty. A, Short axis from apex to base (I to 8) 
shows anterior, anteroseptal, inferoseptal and inferior ischemia and 
inferior myocardial infarction. B, Horizontal long axis from superior 
to inferior (I to 6) shows anteroseptal and inferoseptal ischemia. C, 
Vertical long axis from septal to lateral (I to 3) shows inferoapical 
ischemia and myocardial infarction. Prediction: Restenosis of left 
anterior descending artery, patency of obtuse marginal artery. 
Angiography: 95% left anterior descending stenosis, patency of 
obtuse marginal artery. srR = immediate postexercise images; 
4HR = images 4 hours postexercise. 
asymptomatic patients who had undergone unusually com-
plex angioplasty and who might be expected to have a higher 
restenosis rate. Similarly, the asymptomatic patients with 
angina before angioplasty who were referred by their physi-
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Figure 3. SPECr thallium images in a 65 year old asymptomatic 
man 6 months after left circumflex and right coronary artery 
angioplasty. A, Short axis from apex to base (1 to 7) shows 
inferolateral and inferior ischemia. B, Horizontal long axis from 
superior to inferior (I to 7) shows inferolateral ischemia. C, Vertical 
long axis from septal to lateral (I to 4) shows inferior ischemia. 
Prediction: Restenosis of both left circumflex and right coronary 
arteries. Angiography: 85% left circumflex and 80% right coronary 
artery stenoses. 
cians after abnormal exercise testing are not a random 
sample. The asymptomatic patients who were free of symp-
toms before angioplasty as well have not been previously 
described in published reports and are clearly a selected 
group. 
However, the purpose of this study was not to define the 
frequency of restenosis in asymptomatic patients but rather 
to assess the ability of SPECT thallium imaging to detect 
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restenosis in asymptomatic and symptomatic patients. The 
arteriographic characteristics, incidence of restenosis, per-
cent diameter reductions (Table 3) and exercise performance 
(Table 2) were remarkably similar in both the symptomatic 
and asymptomatic patients; therefore, these patients can be 
defined as populations with similar disease prevalence and 
exercise variables on which to base valid comparisons of the 
utility of a diagnostic tool. 
SPECT thallium imaging and exercise ECG. Although 
prediction of future restenosis by exercise ECG (12) and 
thallium-201 imaging (13,14) within the 1st week of coronary 
angioplasty has been studied, there are no data regarding the 
detection of restenosis by thallium-201 imaging and compar-
ison with exercise ECG in either symptomatic or asympto-
matic patients, evaluation of individual vessel restenosis or 
comparison of the amount of ischemia associated with silent 
and symptomatic restenosis. 
Exercise ECG. The relatively low sensitivity and accu-
racy of exercise ECG for detecting restenosis is consistent 
with prior reports in symptomatic (11,15) and asymptomatic 
(16) patients, as is the 40% sensitivity for exercise ECG in 
silent ischemia, independent of restenosis (9,17,18). The 
value of exercise ECG is further limited by the lack of 
applicability to patients with noninterpretable tracings (left 
bundle branch block, digoxin, marked baseline ST and T 
wave abnormalities) and the absence of vascular localizing 
information, which may be crucial to patient management. 
SPECT thallium imaging. Our study demonstrates that 
SPECT thallium imaging is an excellent tool for detecting 
both silent and symptomatic restenosis (Tables 4 and 5), with 
significantly higher sensitivity and accuracy than exercise 
ECG (Table 4). Our results for restenosis detection, which 
rely on visually interpreted SPECT imaging, are similar or 
slightly superior to those in prior reports (19-22) using 
SPECT imaging with or without quantitative analysis to 
detect coronary artery disease and individual vessel stenosis 
not related to coronary angioplasty. 
We (9) have previously shown that patients with chronic 
coronary artery disease with silent or symptomatic ischemia 
during exercise have similar amounts of ischemic myocar-
dium by SPECr imaging; almost all of the patients presented 
with angina but 75% underwent exercise testing without 
chest pain. The present study extends the comparison to a 
group that is entirely asymptomatic after angioplasty and 
demonstrates, on a vessel by vessel basis, that the amount 
and degree of ischemia associated with restenosis are similar 
in patients with silent or symptomatic ischemia (Table 6). 
The accurate identification of the restenotic vessel and 
the ability to assess the amount of ischemic myocardium 
have an important role in decision making. Figure 2 shows a 
SPECT thallium image from a patient in whom a finding of 
left anterior descending artery restenosis with associated 
massive ischemia supported early intervention. If obtuse 
marginal artery restenosis with a smaller amount of ischemia 
had been the only finding, a less aggressive approach might 
be considered. 
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Clinical implications. Many reports document that in 
patients who have silent ischemia by ECG criteria the degree 
of coronary artery disease is similar (10,17,23-25) and the 
prognosis is similar or worse (10,17,23-28) than that of 
patients who have angina. More recently, prognostic studies 
using either thallium-201 perfusion criteria (29-31) or exer-
cise radio nuclide ventriculography (18) to define silent ische-
mia have confirmed that patients with silent and sympto-
matic ischemia have comparable risks. The previous study 
from our laboratory (9), a planar thallium-201 study (32) in a 
general coronary artery disease population and the present 
study in patients with restenosis after angioplasty reveal the 
physiologic basis for the similar prognosis by showing that 
equal amounts of ischemic myocardium are present in silent 
and symptomatic ischemia. 
Although there are no prognostic studies of silent ische-
mia after angioplasty in asymptomatic patients, there is no 
reason to assume that the outcome would be different from 
prior studies in such patients without angioplasty, especially 
since the degree of restenosis and amount of ischemic 
myocardium are similar to those in patients with sympto-
matic restenosis. Although no published data are available 
with regard to angioplasty performed for silent restenosis, 
recent reports (33-35) demonstrate comparable outcomes for 
angioplasty in the settings of silent and symptomatic ische-
mia. 
Thus, a wealth of data are accumulating to support the 
recent comment of Chatterjee (36) that "the time has ar-
rived . . . to direct therapeutic objectives for the detection 
and treatment of ischemia whether or not it manifests 
clinically or remains silent." The present study shows that 
SPECT thallium-201 imaging has excellent and comparable 
results for detection and localization of ischemia secondary 
to restenosis in both asymptomatic and symptomatic pa-
tients after coronary angioplasty. 
In the earlier days of angioplasty, the reported restenosis 
rates were 20% to 35% (1,2,37,38). Now that this procedure 
is performed for multiple vessel stenoses (39,40), total oc-
clusion (41) and unstable angina (42), the restenosis rates 
may rise to 40% to 50%. The previously reported restenosis 
rates of 14% to 16% (1,2,11) in asymptomatic patients were 
in populations in which 85% of patients underwent only 
single vessel angioplasty, 75% of whom underwent the 
procedure before 1984, when cases were less complex. 
Therefore, one may assume that the present restenosis rate 
in asymptomatic patients is very likely higher than 14% to 
16%. Moreover, a recent study (3) demonstrated that 33% of 
restenoses were associated with an asymptomatic state. 
Thus, the prevalence of restenosis in both symptomatic and 
asymptomatic patients after angioplasty is in the range that, 
according to Bayes' theorem (43), greatly enhances the value 
of the accurate diagnostic examination. 
We recommend that SPECT thallium-201 imaging be 
performed after coronary angioplasty in all symptomatic 
patients. Only 50% to 60% of symptomatic patients have 
restenosis, which can be accurately identified by the SPECT 
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evaluation. In asymptomatic patients who undergo complex 
angioplasty, in whom a high restenosis rate is anticipated 
(39-42), SPECT imaging should be performed no later than 
6 months after angioplasty, the period during which almost 
all restenoses occur (44,45). In asymptomatic patients who 
undergo simple angioplasty, in whom a lower restenosis rate 
is expected, SPECT imaging should be considered; the lower 
prevalence of restenosis in this subset requires a highly 
accurate SPECT evaluation for an enhanced diagnostic 
yield. 
We acknowledge the help of Steve Lugon in typing this manuscript. 
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